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Background
Multiple sclerosis (MS) is a chronic, complex, autoim-
mune, demyelinating disease that affects the Central
Nervous System. Cytokine gene polymorhism according
to the latest studies, may be considered as an important
prognostic indicator in a vast number of autoimmune dis-
eases.
Materials and methods
We investigated 13 cytokine gene polymorphisms in 40
M/S patients and 104 healthy control group. From those
40 patients, 20(group I) were presented with relapsing-
remitting type of the disease and the other 20 (group II)
with secondary progressive type. Cytokine gene poly-
morhism was determined by using the PCR-SSP method
(Invitrogen, Dynal, Wisconsin, USA).
Results
IL 1a - 889C/T genotype was more frequent in group I
patients in comparison to group II (80% vs 40%,
p<0,001). IL-2-330/+166 TG/TT and TNFa -308/-238 GG/
AG genotypes were also statistically more frequent in
group I than in group II (40% vs 10%, p<0,0001 and 50%
vs 20%, p<0,001). IL1a -889 C/C genotype and IL4Ra
+1902 A/A genotype were found more frequently in group
II than in group I patients (60% vs 20%, p<0,001 and
80% vs 50%, p<0,0001).
Conclusions
These preliminary results of the present study suggest that
gene polymorphism of the above cytokine may play a sig-
nificant role in M/S patients evaluation and prognosis.
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